Evidence map›Paper›PMID 33161494›Full record

ReviewCurrent allergy and asthma reports2020

Olfactory Dysfunction in a Mexican Population Outside of COVID-19 Pandemic: Prevalence and Associated Factors (the OLFAMEX Study).

Irma Yolanda Castillo-López, Luis Humberto Govea-Camacho, Iván Alejandro Rodríguez-Torres, Denisse Alejandra Recio-Macías, Isam Alobid, Joaquim Mullol

Open access · bronzeAbstract readReview
In one paragraph

Review in Current allergy and asthma reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 24 citations in OpenAlex.

  1. Olfactory Dysfunction and Cognitive Decline: Are They Related?Current allergy and asthma reports · 2025
    Review
  2. Olfactory function in diabetes mellitus.Journal of clinical & translational endocrinology · 2024
    Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Irma Yolanda Castillo-LópezOtolaryngology Department, Specialties Hospital of the National Medical Center of the West, Mexican Institute of Social Security, Independencia Oriente 1000, 44340, Guadalajara, Jalisco, Mexico. irma.castillol@imss.gob.mx.
Luis Humberto Govea-CamachoOtolaryngology Department, Specialties Hospital of the National Medical Center of the West, Mexican Institute of Social Security, Independencia Oriente 1000, 44340, Guadalajara, Jalisco, Mexico.
Iván Alejandro Rodríguez-TorresArea of Chronic Disease and Cancer Detection, Primary Comprehensive Healthcare Administration, IMSS, Mexico City, Mexico.
Denisse Alejandra Recio-MacíasOtolaryngology Department, Specialties Hospital of the National Medical Center of the West, Mexican Institute of Social Security, Independencia Oriente 1000, 44340, Guadalajara, Jalisco, Mexico.
Isam AlobidRhinology Unit and Smell Clinic, Otorhinolaryngology Department, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain.
Joaquim MullolRhinology Unit and Smell Clinic, Otorhinolaryngology Department, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain. jmullol@clinic.cat.
Mexican Social Security Institute · MXCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewTo study the prevalence of olfactory loss and its associated factors in a Mexican population a cross-sectional analytical study based on a population interviewed about health, epidemiologic aspects, and sense of smell (tested with four scents: rose, banana, perfume, and gas) was conducted to evaluate olfactory detection, memory, and identification. Levels of sense of smell perception were determined when the participants detected, recognized, or identified all (normosmia), 1-3 (hyposmia), or none (anosmia) of the odorants. Associated factors of olfactory dysfunction were identified by multivariate analysis (odds ratio, 95%CI). RECENT

findingsOlfactory dysfunction is a prevalent disorder affecting up to 20% of the general population. In addition to viral infection, including COVID-19, a number of other causes and factors may also be involved. 1,956 surveys were conducted and 1,921 were analyzed. Most of the participants (62.1%) were women. The general prevalence of olfactory dysfunction, regarding detection, was 7.2% (7.1% hyposmia, 0.1% anosmia). Age-related olfactory deterioration was observed in both sexes from the 5th decade of life (OR 2.74, p = 0.0050). Women showed better olfactory identification (OR 0.73, p = 0.0010). Obesity (OR 1.97, p = 0.0070), low educational level, bad/very bad self-perceived olfactory function (OR 2.74, p = 0.0050), olfactory loss for less than one week (OR 1.35, p = 0.0030), exposure to toxics/irritants (OR 1.31, p = 0.0030), active smoking (OR 1.58, p < 0.0010), and type 2 diabetes mellitus (OR 2.68, 95%CI 1.74-4.10, p < 0.0001) were identified as factors associated with olfactory dysfunction. These results in a Mexican population suggest better olfactory identification (verbalization) in females. Age was a determining factor in the olfactory deterioration process and obesity and diabetes mellitus were also associated with olfactory disorders. Finally, these findings reinforce the differential diagnosis with other potential causes of sense of smell loss, during the COVID-19 outbreak.

Indexed as

AdolescentAdultAgedAged, 80 and overBetacoronavirusCoronavirus InfectionsCOVID-19Cross-Sectional StudiesFemaleHumansMaleMexicoMiddle AgedOlfaction DisordersPandemicsPneumonia, ViralAnosmiaCOVID-19OdorantsOlfactory disordersPrevalenceSurvey

Identifiers

PMID33161494
PMCPMC7649040
OpenAlexW3103149027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.